Biomarkers: A Definite Plus in Pneumonia
During the past few years, biomarkers have emerged as an indispensible tool in the diagnosis of pneumonia. To find an ideal diagnostic biomarker for pneumonia is not an easy task. Not only should it allow an early diagnosis of the condition, but it should also allow differential diagnosis from other...
Saved in:
Main Authors: | Hanssa Summah, Jie-Ming Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2009/675753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of RAGE and OSM as New Prognosis Biomarkers of Severe Pneumonia
by: Jing Lei, et al.
Published: (2022-01-01) -
Identification of circulating Tfh/Th subsets as a biomarker of developed hospital-acquired pneumonia
by: Yuan Peng, et al.
Published: (2025-01-01) -
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01) -
Glucocorticosteroid in Treatment of Severe Pneumonia
by: Felinda Ariani, et al.
Published: (2013-01-01) -
Leto plus pomeni plus: vpliv Leta plus na mednarodne študente in njihovo prilagajanje na življenje v Sloveniji
by: Nataša Pirih Svetina
Published: (2024-12-01)